591 related articles for article (PubMed ID: 28960498)
1. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
Rees JMB; Wood AM; Burgess S
Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
Bowden J; Davey Smith G; Burgess S
Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
[TBL] [Abstract][Full Text] [Related]
3. Interpreting findings from Mendelian randomization using the MR-Egger method.
Burgess S; Thompson SG
Eur J Epidemiol; 2017 May; 32(5):377-389. PubMed ID: 28527048
[TBL] [Abstract][Full Text] [Related]
4. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.
Burgess S; Thompson SG
Am J Epidemiol; 2015 Feb; 181(4):251-60. PubMed ID: 25632051
[TBL] [Abstract][Full Text] [Related]
5. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.
Bowden J; Davey Smith G; Haycock PC; Burgess S
Genet Epidemiol; 2016 May; 40(4):304-14. PubMed ID: 27061298
[TBL] [Abstract][Full Text] [Related]
6. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.
Bowden J; Del Greco M F; Minelli C; Davey Smith G; Sheehan NA; Thompson JR
Int J Epidemiol; 2016 Dec; 45(6):1961-1974. PubMed ID: 27616674
[TBL] [Abstract][Full Text] [Related]
7. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings.
Karageorgiou V; Tyrrell J; Mckinley TJ; Bowden J
Genet Epidemiol; 2023 Mar; 47(2):135-151. PubMed ID: 36682072
[TBL] [Abstract][Full Text] [Related]
8. Extending Causality Tests with Genetic Instruments: An Integration of Mendelian Randomization with the Classical Twin Design.
Minică CC; Dolan CV; Boomsma DI; de Geus E; Neale MC
Behav Genet; 2018 Jul; 48(4):337-349. PubMed ID: 29882082
[TBL] [Abstract][Full Text] [Related]
9. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.
Hartwig FP; Davey Smith G; Bowden J
Int J Epidemiol; 2017 Dec; 46(6):1985-1998. PubMed ID: 29040600
[TBL] [Abstract][Full Text] [Related]
10. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.
White J; Sofat R; Hemani G; Shah T; Engmann J; Dale C; Shah S; Kruger FA; Giambartolomei C; Swerdlow DI; Palmer T; McLachlan S; Langenberg C; Zabaneh D; Lovering R; Cavadino A; Jefferis B; Finan C; Wong A; Amuzu A; Ong K; Gaunt TR; Warren H; Davies TL; Drenos F; Cooper J; Ebrahim S; Lawlor DA; Talmud PJ; Humphries SE; Power C; Hypponen E; Richards M; Hardy R; Kuh D; Wareham N; Ben-Shlomo Y; Day IN; Whincup P; Morris R; Strachan MW; Price J; Kumari M; Kivimaki M; Plagnol V; Whittaker JC; ; Smith GD; Dudbridge F; Casas JP; Holmes MV; Hingorani AD;
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):327-36. PubMed ID: 26781229
[TBL] [Abstract][Full Text] [Related]
11. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
Lanktree MB; Thériault S; Walsh M; Paré G
Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
[TBL] [Abstract][Full Text] [Related]
12. An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting.
Grant AJ; Burgess S
Biostatistics; 2022 Apr; 23(2):609-625. PubMed ID: 33155035
[TBL] [Abstract][Full Text] [Related]
13. Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct Effects.
Dai JY; Peters U; Wang X; Kocarnik J; Chang-Claude J; Slattery ML; Chan A; Lemire M; Berndt SI; Casey G; Song M; Jenkins MA; Brenner H; Thrift AP; White E; Hsu L
Am J Epidemiol; 2018 Dec; 187(12):2672-2680. PubMed ID: 30188971
[TBL] [Abstract][Full Text] [Related]
14. MRCIP: a robust Mendelian randomization method accounting for correlated and idiosyncratic pleiotropy.
Xu S; Fung WK; Liu Z
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33704372
[TBL] [Abstract][Full Text] [Related]
15. Mendelian randomization with Egger pleiotropy correction and weakly informative Bayesian priors.
Schmidt AF; Dudbridge F
Int J Epidemiol; 2018 Aug; 47(4):1217-1228. PubMed ID: 29253155
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropy-robust Mendelian randomization.
van Kippersluis H; Rietveld CA
Int J Epidemiol; 2018 Aug; 47(4):1279-1288. PubMed ID: 28338774
[TBL] [Abstract][Full Text] [Related]
17. Mendelian randomization incorporating uncertainty about pleiotropy.
Thompson JR; Minelli C; Bowden J; Del Greco FM; Gill D; Jones EM; Shapland CY; Sheehan NA
Stat Med; 2017 Dec; 36(29):4627-4645. PubMed ID: 28850703
[TBL] [Abstract][Full Text] [Related]
18. Impact of nonrandom selection mechanisms on the causal effect estimation for two-sample Mendelian randomization methods.
Yu Y; Hou L; Shi X; Sun X; Liu X; Yu Y; Yuan Z; Li H; Xue F
PLoS Genet; 2022 Mar; 18(3):e1010107. PubMed ID: 35298462
[TBL] [Abstract][Full Text] [Related]
19. Constrained instruments and their application to Mendelian randomization with pleiotropy.
Jiang L; Oualkacha K; Didelez V; Ciampi A; Rosa-Neto P; Benedet AL; Mathotaarachchi S; Richards JB; Greenwood CMT;
Genet Epidemiol; 2019 Jun; 43(4):373-401. PubMed ID: 30635941
[TBL] [Abstract][Full Text] [Related]
20. Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model.
Lin Z; Deng Y; Pan W
PLoS Genet; 2021 Nov; 17(11):e1009922. PubMed ID: 34793444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
